StockData
biote Corp. logo

biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3069% below fair value
$0.99+0.03 (+3.09%)

Close on Nov 17, 2026Market cap $35.57MP/E 9.9Yield –

biote pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

biote's pe ratio was 10.9× on Nov 11, 2026, against 3.4× a year earlier. Over the last 3 years it ranged from 1.8× to 654.6×, with a median of 16.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.9×+7.6
2025Dec 31, 20253.3×−25.5
2024Dec 31, 202428.8×−625.8
2022Oct 31, 2022654.6×–

More biote figures

See a number that looks wrong?